Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter Schellekens

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pediatric Nephrology (Berlin, Germany)|January 27, 2021
Cytopenia in autosomal dominant polycystic kidney disease (ADPKD): merely an association or a disease-related feature with prognostic implications?Pieter Schellekens, Willem Roosens, Isabelle Meyts, et al.
The New England Journal of Medicine|November 5, 2025
Spiraling into a Distant PastJef Van den Eynde, Claire van der Pluijm, Pieter Schellekens, et al.
Clinical Kidney Journal|December 4, 2023
Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-upPieter Schellekens, Elisabet Van Loon, Maarten Coemans, et al.
Pediatric Nephrology (Berlin, Germany)|March 20, 2023
Low agreement between various eGFR formulae in pediatric and young adult ADPKD patientsPieter Schellekens, Marcelien Verjans, Peter Janssens, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 17, 2023
Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound VolumetryLuc Breysem, Frederik De Keyzer, Pieter Schellekens, et al.
Pediatric Nephrology (Berlin, Germany)|February 1, 2025
Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40Stijn Wigerinck, Pieter Schellekens, Byron H Smith, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pediatric Nephrology (Berlin, Germany)|January 27, 2021
Cytopenia in autosomal dominant polycystic kidney disease (ADPKD): merely an association or a disease-related feature with prognostic implications?Pieter Schellekens, Willem Roosens, Isabelle Meyts, et al.
The New England Journal of Medicine|November 5, 2025
Spiraling into a Distant PastJef Van den Eynde, Claire van der Pluijm, Pieter Schellekens, et al.
Clinical Kidney Journal|December 4, 2023
Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-upPieter Schellekens, Elisabet Van Loon, Maarten Coemans, et al.
Pediatric Nephrology (Berlin, Germany)|March 20, 2023
Low agreement between various eGFR formulae in pediatric and young adult ADPKD patientsPieter Schellekens, Marcelien Verjans, Peter Janssens, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 17, 2023
Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound VolumetryLuc Breysem, Frederik De Keyzer, Pieter Schellekens, et al.
Pediatric Nephrology (Berlin, Germany)|February 1, 2025
Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40Stijn Wigerinck, Pieter Schellekens, Byron H Smith, et al.
Pageof 1